Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Dermacontrol Oil Control Moisturizer SPF 30
NCT01887808 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2022-07-29
Summary
Determine if Cetaphil DermaControl Oil Control Moisturizer SPF 30 proves to be a contact sensitizer or irritant in certain individuals
Conditions
- Skin Irritation
Interventions
- OTHER
-
Cetaphil DermaControl Oil Control Moisturizer SPF 30
Sponsors & Collaborators
-
Galderma R&D
lead INDUSTRY
Principal Investigators
-
Mayya Tastene, MD · AMA Laboratories
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2013-01-31
More Related Trials
-
Patch Test Skin Irritation/Sensitization of Cetaphil Restoraderm Skin Restoring Body Wash
NCT01892410 ·Status: COMPLETED ·Phase: NA
-
Cumulative Irritation Patch Test
NCT01842711 ·Status: COMPLETED
-
Prospective Single Center Randomized Double Blind Controlled Tolerability Trial of Six Hair Cleansing Conditioners
NCT03483025 ·Status: COMPLETED ·Phase: NA
-
To Evaluate Skin Irritation and Skin Sensitisation of Developmental Cosmetic Facial Products
NCT04007159 ·Status: COMPLETED ·Phase: NA
-
Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity
NCT02441608 ·Status: COMPLETED ·Phase: NA
-
To Check Dermatological Safety of Test Products by 24 Hours Patch Test on Adult Healthy Human Subjects.
NCT06631898 ·Status: COMPLETED ·Phase: NA
-
Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity
NCT03015103 ·Status: UNKNOWN ·Phase: NA
-
A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin
NCT02620293 ·Status: COMPLETED ·Phase: PHASE1
-
Repeat Insult Patch Test APPENDIX I to HRL Standard Protocol #100
NCT03450070 ·Status: COMPLETED ·Phase: NA
-
To Investigate Primary Irritation Potential of Four Skin Serum Products on Human Subjects Assessed by 24 Hour Patch Test
NCT03233009 ·Status: COMPLETED ·Phase: NA
-
50 Human Subject Repeat Insult Patch Test
NCT04498676 ·Status: COMPLETED ·Phase: NA
-
Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Itch in Adult Hemodialysis Patients
NCT00693654 ·Status: COMPLETED ·Phase: PHASE4
-
Human Comedogenicity Test
NCT03428997 ·Status: COMPLETED ·Phase: NA
-
Compatibility of a Mild, Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis
NCT00843466 ·Status: COMPLETED ·Phase: NA
-
Compare the Skin Barrier Repair Function of Two Ceramide Containing Moisturizers
NCT04185025 ·Status: UNKNOWN ·Phase: NA
-
To Assess Skin Safety of Test Product(s) by Patch Test on Adult Healthy Human Subjects
NCT07109453 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of Effects of HP828-101 for Moisture Associated Skin Damage
NCT01108523 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Skin Sensitization Test (Modified Draize-95 Test)
NCT03886987 ·Status: COMPLETED ·Phase: NA
-
A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests
NCT03406117 ·Status: COMPLETED ·Phase: PHASE4
-
Dermatological Evaluation of Topical Compatibility, Primary Skin Irritability, Accumulated Skin Irritability, and Dermal Sensitisation
NCT02419248 ·Status: COMPLETED
-
Dermal Tolerability of Dapsone Gel in Healthy Volunteers
NCT02117752 ·Status: COMPLETED ·Phase: PHASE1
-
Cumulative Irritation Potential of 828 Ointment
NCT00767455 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Cicaplast in Subjects With Skin Irritation
NCT05767333 ·Status: COMPLETED
-
Cumulative Irritation Test of PAC-14028 in Healthy Volunteers
NCT01638117 ·Status: COMPLETED ·Phase: PHASE1
-
Dermatological Evaluation of Topical Compatibility, Primary Skin Irritability, Accumulated Skin Irritability, and Dermal Sensitisation
NCT03007498 ·Status: UNKNOWN